Mary is the Oral Oncolytic Nurse Navigator for the Norton Cancer Institute in Louisville, Kentucky. She serves on the Executive Council for the National Community Oncology Dispensing Association and is past President of the Greater Louisville Oncology Nursing Society. She has authored chapters for Oncology Nursing Society’s Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2018 edition), including the chapter on oral adherence. She is a co-author of the recently published ASCO/NCODA Patient-Centered Standards for Medically Integrated Dispensing.
Mary is a graduate of the University of Kentucky College of Nursing with more than 30 years of experience in oncology nursing.
Kirollos Hanna, PharmD, BCPS, BCOP, is assistant professor of pharmacy at the Mayo Clinic College of Medicine, and primarily practices hematology/oncology pharmacy at the University of Minnesota Medical Center and Mayo Clinic.
Dr. Hanna is a nationally recognized expert in genitourinary cancers, multiple myeloma, and chronic leukemias. His research interests focus on outcome measures for patients with rare diseases. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, American Journal of Health-System Pharmacy, Journal of Oncology Pharmacy Practice, and Journal of Hematology Oncology Pharmacy. He is a member of the 2018 inaugural 40 Under 40 Rising Stars and Emerging Leaders in Cancer class. He is also an active member of the Patient-Centered Outcomes Research Institute, Aplastic Anemia & MDS International Foundation, and the American College of Clinical Pharmacy.
On a national level, Dr. Hanna serves on the executive council for the National Oncology Community Dispensing Association (NCODA) and as president for the Southern Affiliate Chapter of the Minnesota Society of Health-System Pharmacists (MSHP). He is an active member and has been an invited speaker for NCODA, Hematology/Oncology Pharmacy Association, MSHP, among others and has been featured on The Video Journal of Oncology and Specialty Pharmacy Times.
Dr. Hanna received his Doctor of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital in Nashville, Tennessee, and his oncology residency at St. Luke's Mountain States Tumor Institute in Boise, Idaho.
Dr. Hari is the Armand J. Quick/William F. Stapp Professor of Hematology at the Medical College of Wisconsin, where he is also a chief in the Division of Hematology and Oncology in the Department of Medicine. After attending medical school in India, Dr. Hari completed his training in internal medicine and hematology in the United Kingdom and then in the Medical Oncology and Transplantation Program at the Medical College of Wisconsin. Dr. Hari’s primary clinical interests are in cellular therapies and plasma cell disorders, including multiple myeloma, amyloidosis, and other monoclonal gammopathies.
Kathy W. Oubre, MS, is the Chief Operating Officer for Pontchartrain Cancer Center with locations in Covington and Hammond, Louisiana. In this role, she provides non-clinical leadership for all aspects of the practice, including financial counseling, policy/procedure development, revenue cycle management, advanced care planning, survivorship care and clinical trials.
She is the President of the Coalition of Hematology and Oncology Practices (CHOP) and President-Elect of the Louisiana Medical Group Managers Association. Kathy is also a Board member of the Community Oncology Alliance (COA) and serves on the COA Government Affairs and Biosimilars Committees. She is a member of the Quality Cancer Care Alliance (QCCA) and serves as the Chair of Pharmaceutical and Operational Purchasing. Kathy is also the Advisory Board President for You Night Empowering Events, which is a year-round cancer survivorship program for women. Other memberships include ACCC and National Community Oncology Dispensing Association (NCODA).
Ray D. Page, DO, PhD, FACOI, FASCO, has practiced medical oncology for 23 years. He is President of The Center for Cancer and Blood Disorders, and has been at the forefront of community oncology practice transformation participating in a variety of payment reform models and development of pathway systems. As Director of Research for The Center for Cancer and Blood Disorders, Dr. Page has been the Principal Investigator of over 200 clinical trials and is well published on a variety of cancer-related topics. He has a particular interest in healthcare policy and was recently acknowledged as the American Society of Clinical Oncology (ASCO) Advocate of the Year.
Dr. Page actively serves ASCO, including as the current Chair of the Clinical Practice Committee, Nominating Committee, Government Relations Committee, ASCO Delegate to the AMA House of Delegates, and State Affiliate Council past chair. He has contributed to the publication of several ASCO Policy statements on Pathways, 340B, Site-Neutrality, Safe Handling of Hazardous Drugs, and ASCO’s Patient Centered Oncology Payment model.
Laura S. Wood, RN, MSN, OCN, is the renal cancer clinical research coordinator in the solid tumor oncology program at the Cleveland Clinic Cancer Institute in Cleveland, Ohio.
She received her bachelor’s and master’s degrees in nursing from Kent State University in Kent, Ohio. Ms. Wood has worked in a variety of oncology settings since 1981, and has been in her current position since 1994.
Ms. Wood is active in the local and national Oncology Nursing Society (ONS) and is a member of the ONS Clinical Trials and Biotherapy Special Interest Groups. She is a national and international lecturer on topics related to oncology nursing, and has authored many book chapters and journal articles on therapeutic approaches and nursing care in the management of cancer. Laura was the recipient of the 2012 Oncology Nursing Society Clinical Lectureship Award, the 2005 Emma Barr Award for Clinical Excellence from the Cleveland Clinic Foundation, and the 2004 Oncology Nursing Society Excellence in Biotherapy Nursing Award.
Nikki Barkett, RN, BSN, OCN, is the Malignant Hematology Nurse Navigator at the University of Arizona Cancer Center.
She has presented on managing “Relapsed/Refractory Myeloma in the Era of New Agents for Treatment,” “Multiple Myeloma: An Update on the Disease, Diagnosis, and Treatments,” and managing treatment side effects for patients living with lymphoma. She is also a co-author on a case report and literature review looking at survival rates among patients with refractory IgD multiple myeloma treated with daratumumab, and a contributing author for “Building Blocks of Hope, Strategies for Patients and Caregivers Living with MDS.”
Nikki is currently a member of the Financial Toxicity Committee at the University of Arizona Cancer Center, evaluating the use of screening tools to proactively identify patients at high-risk for financial distress, improving health literacy by educating and evaluating patients at key time points throughout their cancer journey, and evaluating the efficacy of an insurance navigator housed within the clinic.
Clara Lambert is an active member of the Academy of Oncology Nurse & Patient Navigators (AONN+). She participates in the Conference Planning, Policy and Advocacy (co-chair of Advocacy), and Technology Committees, as well as speaking on financial navigation and other topics.
She is also the director of financial navigation at TailorMed. Previously, she spent seven years as a financial navigator in Michigan and Illinois hospital systems.
In 2013, she helped to pioneer a nationally recognized financial navigation program at the Cowell Family Cancer Center in Traverse City, Michigan. In 2018, she moved to the Chicagoland area to work as a financial navigator at the Bhorade Cancer Center at Advocate Good Samaritan Hospital, and was asked to work with a task force to implement financial navigation technology throughout the Advocate Aurora healthcare system.
Clara has been influential in the development of the role of financial navigator at her cancer centers, hospital systems, and nationwide. She was recognized in 2019 with an Academy of Oncology Nurse and Patient Navigators (AONN+) Leadership Council Award: Putting Evidence into Practice. Previously, she served as chair of the Association of Community Cancer Centers (ACCC) Financial Advocacy Network Advisory Committee (2018-2019).
She has a bachelors degree in Integrated Professional Studies: Business, Healthcare Administration & Information Technology from Davenport University in Grand Rapids, Michigan.